Two-(2D) and three-dimensional (3D) ultrasound imaging is used frequently for tubal patency testing with relatively high accuracy, particularly when performed by experts and using foam as contrast medium 1 . However, there are still some drawbacks related to the technique that preclude its worldwide use, including the cost and availability of contrast media, the procedure-related pain and the need for appropriate training to obtain competence in the performance of tubal patency testing 1 .In this article, we describe a novel technique, hysterosalpingo-lidocaine-foam sonography combined with power Doppler imaging (HyLiFoSy-PD), which allows assessment of the 'flaming tube' sign as an indicator of tubal patency. We believe that this technique offers advantages related to cost, availability and ease of image recognition; additionally, the use of lidocaine in the contrast agent could potentially reduce the pain associated with the procedure. Technique 1. Specific patient preparation is not necessary; however, offering the patient a painkiller containing paracetamol (500 mg) and codeine (30 mg) 1 h before the procedure should be considered. 2. The examination is performed between days 5 and 10 of the menstrual cycle, with the patient in gynecological position, preferably with the aid of one assistant. 3. Initially, real-time 2D and 3D ultrasound assessment of the pelvic organs is performed (in our case, using a GE Voluson E8 ultrasound system (GE Medical Systems, Zipf, Austria)). Note that the 3D technique is not essential as examination of the pelvic organs and uterine cavity and evaluation of tubal patency can be performed accurately using only real-time 2D ultrasound in machines not equipped with 3D technology.4. Following the initial ultrasound scan, the external cervical os is identified with the aid of a vaginal speculum. A sterile 5-Fr balloon catheter (Softinjector, RI.MOS, Mirandola, Italy) is introduced into the cervical canal or the uterine cavity, similarly to other uterine cavity and tubal patency contrast tests. Saline contrast sonohysterography is performed initially, using real-time 2D and 3D ultrasound to assess the uterine cavity for anomalies and lesions 1 . 5. The foam contrast agent is created by combining 3-4 mL of 2% lidocaine gel (each mL contains 20 mg of lidocaine hydrochloride, water, hypromellose, methylparaben, propylparaben and hydrochloric acid; pH is between 6.0 and 7.0), 12-13 mL of saline and 3 mL air. The use of lidocaine gel up to 10% w/w is considered to be safe for vaginal, intrauterine and intra-abdominal use 2,3 . The assistant creates the foam immediately before application, moving the mixture between two connected 20-mL syringes, until a whitish suspension is obtained (approximately 10-20 times). 6. Before injecting the contrast agent, an attempt is made to identify both uterine horns, including the intramural part of the uterine tubes in the transverse section of uterus, to be used as starting position for real-time 2D evaluation and acquisition of 3D volumes. 7. The assistan...